Europe Approves First-Ever Treatment for Rett Syndrome

Families across Europe now have access to DAYBU, the first approved treatment for Rett syndrome, a devastating neurological condition that mainly affects young girls.

The drug will reach patients in all 27 EU countries plus Iceland, Liechtenstein, and Norway starting in 2026.